Now Reading
What Should the Emmys do with The Bear: TV’s Top 5 podcast

What Should the Emmys do with The Bear: TV’s Top 5 podcast

Welcome to the 262nd episode of TV’s Top 5, The Hollywood Reporter’s TV podcast.

Every week, hosts Lesley Goldberg (West Coast TV editor) and Daniel Fienberg (chief TV critic) break down the latest TV news with context from the business and critical sides, welcome showrunners, executives and other guests, and provide a critical guide of what to watch (or skip, as the case may be).

Here’s how this week’s episode plays out:

1. Headlines

Marion Cotillard, Charlie Hunnam, Sarah Snook, All American, Adam Levine and Paul Giamatti lead the week’s top TV headlines.

2. TLC bets on Baldwin

Alec Baldwin, amid an upcoming trial stemming from manslaughter charges over the accidental shooting death of the cinematographer on Rust, has landed his own reality show. TLC this week announced The Baldwins, a so-called “follow-doc” series that brings viewers into the home life of Alec and his wife of 12 years, Hilaria, and their seven children, that will premiere in 2025. Is this image rehab or TLC scraping the bottom of the Dr. Pimple Popper pile?

3. Mailbag!

Have a question you’d like to hear us discuss on the pod? Drop us an email at This week, we discuss Paramount and a possible fire sale; the difference between an HBO and a Max original; and Dan goes deep on what the Emmys should do when it comes to which category The Bear should compete in.

4. ATX TV Festival wrap-up

Just back from Austin, Dan recaps the highs and lows (food-wise!) from his time at the ATX Television Festival.

See Also

5. Critic’s Corner

As usual, we end with Dan’s thoughts on this week’s new and returning series. In this episode, he weighs in on The Acolyte, Clipped, Queenie and Fantasmas.

Hear it all now on TV’s Top 5. Be sure to subscribe to the podcast to never miss an episode. (Reviews welcome!) You can also email us with any topics or Mailbag questions you’d like addressed in future episodes at

Copyright © MetaMedia™ Capital Inc, All right reserved

Scroll To Top